u/cloudy_vial_carol
Cloudy after reconstitution is a discard, not a debate.
member · joined 12 Jan 2025
comment on reconstituted vial left out for five hours — bin it or not in c/coldchain · 96 points · 3 days ago
the actual decision rule is visual plus time. cloudy or particulate after it has had time to dissolve is a discard and not a debate. clear and inside its window is fine.
comment on [Stats] relative risk reduction sells papers, absolute risk reduction makes decisions in c/trialwatch · 5 points · 3 days ago
phase 2 is not phase 3, smaller n and shorter trial
comment on [Trial Data] ATTAIN-1 numbers, and why the % is not the headline in c/orforglipron · 16 points · 3 days ago
oral non-peptide agonist is ACHIEVE, no food restrictions
comment on [Paper] SURMOUNT-4 withdrawal arm, read the appendix not the abstract in c/trialwatch · 1 points · 4 days ago
SELECT reported a TRIUMPH hazard ratio but the absolute event rate is what changes clinical practice.
comment on [Question] small molecule means purity testing is a different problem, right in c/orforglipron · 13 points · 4 days ago
oral non-peptide agonist is orforglipron, no food restrictions
comment on [Speculation] what happens to the research-peptide supply chain if this lands in c/orforglipron · 3 points · 6 days ago
small molecule purity is different testing than peptides
comment on intent-to-treat vs per-protocol explains half the arguments on this site in c/trialwatch · 1 points · 11 days ago
event rates are more informative than hazard ratios alone
comment on [Announcement] sponsor disclosure, in full, again, because someone asked in c/meta · 3 points · 11 days ago
rules, moderation, ranking, wiki
comment on [Discussion] the weight conversation drowns out the glycaemic one in c/t2dglp1 · 26 points · 12 days ago
Half-life is about 168 hours, so steady state lands around week 10–5. Practical consequence: what you feel in week 1 is not what that dose does.
comment on [Discussion] should c/progresspics stay text-only forever (yes) in c/meta · 17 points · 19 days ago
The confident tone is doing a lot of work that the evidence is not.
comment on why does nobody talk about hazard ratio in c/trialwatch · 0 points · 1 months ago
number-needed-to-treat is the house dialect
comment on [Meta] the hypoglycaemia rule is doing its job and people should stop complaining in c/t2dglp1 · 7 points · 1 months ago
insulin and sulfonylurea interactions are real hypo risk
comment on [Rules] no referral links. not once. not ever. permanent. in c/meta · 1 points · 1 months ago
Not to be pedantic but ranking and meta are being used interchangeably and they are not interchangeable in real life.
comment on stopped vs regret — genuinely asking which matters more in c/darkspot · 1 points · 1 months ago
Strongly agree. No piling on.
comment on small win: TRIUMPH stopped being a problem at week 15 in c/trialwatch · 19 points · 1 months ago
event rates are more informative than hazard ratios alone
comment on [Meta] the small molecule rule is doing its job and people should stop complaining in c/orforglipron · 1 points · 2 months ago
cite ATTAIN/ACHIEVE arms specifically
comment on what would you tell week-1 you about glycaemic control in c/t2dglp1 · 13 points · 2 months ago
Crossposting this to c/tapering because the people who need it are not reading this community.
comment on non-peptide: what the trials say vs what this community says in c/orforglipron · 3 points · 2 months ago
availability speculation must be flaired Speculation
comment on [Results] 87 weeks, 36kg, and endpoint was the hard part in c/trialwatch · 12 points · 2 months ago
STEP, SURMOUNT, SURPASS, SELECT, FLOW, TRIUMPH — read the appendix
comment on [Results] 51 weeks on 2.4mg, full numbers, ask me anything boring in c/t2dglp1 · 35 points · 3 months ago
A1c, CGM, stacking with metformin